milestones News
Most Popular milestones Story
Synta gets $15M milestone from GSK
Synta Pharmaceuticals has garnered a $15 million payment from GlaxoSmithKline as part of its collaboration agreement for the cancer drug elesclomol. Elesclomol is in Phase III trials for metastatic... Read more...
Latest Headlines
- December 12, 2008
- November 24, 2008
- November 6, 2008
- October 30, 2008
- October 14, 2008
- July 15, 2008
- June 12, 2008
- June 5, 2008
- June 5, 2008
- June 5, 2008
- May 28, 2008
- May 27, 2008
- May 23, 2008
- May 21, 2008
- May 20, 2008
- May 13, 2008
- May 9, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
